Henry Schein appoints Frederick M. Lowery as CEO

Dental Tribune International

Tue. 13. January 2026

save

MELVILLE, N.Y., US: Henry Schein has announced the appointment of Frederick M. Lowery as CEO, effective from 2 March. Lowery will also join the company’s board of directors at that time. He succeeds Stanley M. Bergman, who will step down after 35 years in the role and continue to serve as chairman of the board to support a smooth leadership transition.

The appointment follows Henry Schein’s announcement in July 2025 that Bergman would retire as CEO at the end of the year. Bergman joined the company in 1980 as its first chief financial officer and assumed leadership in 1989 after the death of then CEO Jay Schein. Under his tenure, Henry Schein transformed from a US-based dental mail order business into a global provider of dental and medical products and solutions.

Lowery brings more than two decades of experience in healthcare leadership to Henry Schein. Most recently, he served as executive vice-president and president of laboratory products and bio-production at Thermo Fisher Scientific, where he led the company’s global distribution operations to above-market performance. His background spans distribution, manufacturing, research and development, marketing and sales, aligning closely with Henry Schein’s business model and its 2025–2027 BOLD+1 strategic plan, which emphasises higher-margin specialty, technology and value-added growth alongside global distribution.

“I am honoured to join Henry Schein at such a pivotal moment. This is an organisation with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service and partnership,” Lowery said in a press release. “I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation.”

“I am very pleased to welcome Fred to Henry Schein,” said Bergman. “Beyond his extensive operational experience, he brings a leadership philosophy that reflects the values that have long defined our company. Fred understands the critical role we play in supporting dental and medical practitioners, and he is exceptionally well equipped to lead Henry Schein into its next phase of growth.”

The CEO succession process was overseen by the nominating and governance committee. Committee Chair Philip A. Laskawy, also lead director of Henry Schein, said: “After a comprehensive search process, we are confident that Fred is the right successor to honour Henry Schein’s proud heritage and accelerate growth and value creation.”

The appointment comes against the backdrop of Henry Schein’s strategic partnership with investment firm KKR, which acquired a significant minority stake in the company in 2025 and appointed representatives to the board. Max Lin, vice-chair of the nominating and governance committee and a partner at KKR, added: “We believe Fred brings a unique combination of healthcare distribution experience, operational best practices and accountable leadership that will accelerate our strategic initiatives and further differentiate Henry Schein as a world-class business.”

Prior to joining Thermo Fisher, Lowery held leadership roles at the Maytag Corp. and General Motors. He holds a master’s degree in manufacturing management from Kettering University (then the GMI Engineering and Management Institute) in Flint in Michigan and a bachelor’s degree in mechanical engineering from Tennessee Technological University in Cookeville, both in the US.

Tags:

To post a reply please login or register

Henry Schein One and AWS collaborate to transform global dentistry with generative AI

AMERICAN FORK, Utah, US: Henry Schein One, a leading global provider of dental technology, today announced a new partnership with Amazon Web Services (AWS),...

“Our innovation focus is on delivering meaningful, clinically relevant solutions”

Henry Schein’s endodontic division is on a fast track to becoming a global leader in root canal treatment solutions. In this interview, Paolo Zanetti, ...

Stanley M. Bergman to retire as Henry Schein CEO

NEW YORK, US: Dental giant Henry Schein has announced that its long-serving CEO, Stanley M. Bergman, will retire at the end of the year, remaining in his ...

Conversations with Henry Schein

COLOGNE, Germany: Yesterday, Henry Schein held an exclusive media session that brought the international dental media into direct dialogue with Stanley M. ...

KKR gains foothold in Henry Schein

NEW YORK, US: Henry Schein is set to have a new major shareholder. The US-based global dental distributor has announced a deal of purchase and collaboration...

Henry Schein announces INT_ENDO campus for all endodontic needs

MELVILLE, N.Y., US: Henry Schein has recently launched the INT_ENDO campus, a new global platform designed to meet the growing needs of dental professionals...

Education

Live webinar
Wed. 14 January 2026
12:00 pm EST (New York)